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Abstract
Background: Adequate recognition of anxiety and depression by general practitioners (GPs) can be improved.
Research on factors that are associated with recognition is limited and shows mixed results. The aim of this study
was to explore which patient and GP characteristics are associated with recognition of anxiety and depression.
Methods: We performed a secondary analysis on data from 444 patients who were recruited for a randomized trial.
Recognition of anxiety and depression was defined in terms of information in the medical records, in patients who
screened positive on the extended Kessler 10 (EK-10). A total of 10 patient and GP characteristics, measured at
baseline, were tested and included in a multilevel regression model to examine their impact on recognition.
Results: Patients who reported a perceived need for psychological care (OR = 2.54, 95% CI 1.60–4.03) and those
with higher 4DSQ distress scores (OR = 1.03; 95% CI 1.00–1.07) were more likely to be recognized. In addition,
patients’ anxiety or depression was less likely to be recognized when GPs were less confident in their abilities to
identify depression (OR = 0.97; 95% CI 0.95–0.99). Patients’ age, chronic medical condition, somatisation, severity of
anxiety and depression, and functional status were not associated with the recognition of anxiety and depression.
Conclusions: There is room for improvement of the recognition of anxiety and depression. Quality improvement
activities that focus on increasing GPs’ confidence in the ability to identify symptoms of distress, anxiety and
depression, as part of care according to guidelines, may improve recognition.
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Background
Anxiety and depression are highly prevalent, negatively
impact everyday functioning, cause great suffering, and
incur high healthcare costs and costs associated with re-
duced productivity [1–3]. Although clinical guidelines are
available [4, 5], the management of these disorders in gen-
eral practice is often suboptimal. Under-recognition of
anxiety and depression has been reported, although more
severe symptoms may be more easily recognized [6, 7].
Adequate recognition, diagnosis and treatment of anxiety
and depression may decrease the burden of disease [8].
With approximately 75% of adult patients visiting their
general practitioner (GP) at least once a year in the
Netherlands, the GP is in a good position to detect anxiety
and depression [9]. In the Netherlands more than 75% of
patients diagnosed with psychological problems are
treated in general practice [10]. Studies showed a wide
range of recognition rates of depression and anxiety
in primary care, also depending on the method of
case ascertainment and the time allowed for GPs to
recognize [11–13]. Recognition rates were higher
when patient medical record extraction was used over
an extended period compared to cross-sectional
methods. In addition, when a less specific definition
of recognition was used, recognition rates were
higher. However, this may also result in more false
positives [14].
Characteristics of both GPs and patients influence rec-
ognition of anxiety and depression. Many patients do
not acknowledge that they suffer from anxiety or depres-
sion, and may present themselves in general practice
with somatic symptoms [15–18]. Both patients and GPs
may prioritise physical problems if they coexist with a
(hidden) depression [19]. Even when a psychiatric diag-
nosis is made the patient or GP may not perceive a need
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for treatment [20]. Furthermore, some GPs find it difficult
to distinguish between ‘normal’ distress and depression re-
quiring treatment [21]. In the presence of chronic physical
health problems GPs and patients tend to normalise dis-
tress [22]. In addition, there are barriers related to the ac-
cess of care (e.g. stigma, lack of information about mental
health and available services) [23].
Adequate recognition, and subsequent treatment,
could improve outcomes for patients. Previous studies
have examined different patient and GP characteristics
as possible factors associated with the recognition of de-
pression and anxiety, showing mixed results. Factors as-
sociated with recognition include female gender,
advanced age, being single, severe depression, comorbid
anxiety or depression, chronic somatic co-morbidity, his-
tory of depression, having disclosed mental health prob-
lems to the GP, and positive attitudes toward help
seeking [7, 14, 24–29]. A few studies also examined
whether primary care physician characteristics, such as
years of experience, education, special interest, know-
ledge and skills, were associated with recognition of de-
pression [7, 24] and anxiety [14]. Wittchen et al. (2001)
found that physicians with more than 5 years of practice
experience were more likely to recognize patients with a
depression. Janssen et al. (2012) and Piek et al. (2012)
concluded that there were no GP characteristics associ-
ated with recognition [7, 14]. Furthermore, GPs’ atti-
tudes likely constitute an important factor affecting the
recognition of anxiety and depression [30–32].
Previous studies showed mixed results regarding fac-
tors associated with recognition and other factors are
rarely studied. The factors include: (i) patient character-
istics: age, married or living together, chronic medical
condition, the perceived need for care, psychological
symptoms and functional status, and (ii) GP characteris-
tics: attitudes toward the management of anxiety and de-
pression. The aim of the current study was to examine
whether these factors are associated with the recognition
of anxiety and depression in general practice.
Methods
Study design
This study is a secondary analysis of data from a cluster
randomized controlled trial of tailored interventions, to
improve the management of anxiety and depression in
primary care (NTR1912) [33]. The aim of the trial was
to determine the clinical and cost effectiveness of tai-
lored interventions to improve compliance with guide-
lines for the recognition of anxiety and depression in
general practice [34–37]. The trial compared training
and feedback for GPs with training and feedback supple-
mented with a tailored intervention. Results showed that
the tailored intervention resulted in increased recogni-
tion of anxiety and depression (42% versus 31%; OR =
1.60; 95% CI:1.01–2.53) [38].The identification of bar-
riers to implementation of guidelines, the development
of interventions targeting these barriers, and the applica-
tion and perceived usefulness of the resulting tailored in-
terventions have been described elsewhere [39]. The
sample size was based on the primary trial objectives.
The trial was approved by the medical ethics committee
of the Institutions for Mental Health (METiGG; Utrecht,
the Netherlands) in 2009.
Study population
The study population included 46 GPs in 23 general
practices (12 practices were randomised to the inter-
vention condition and 11 practices to the control
condition), and all patients aged 18 years or older vis-
iting one of the participating GPs between September
2010 and June 2011. A total of 7410 patients received
an information letter and an invitation to participate
and were asked to complete the extended Kessler 10
(EK-10), a validated screening tool for anxiety and de-
pressive disorder in primary care [40]. The screening
was returned by 1687 patients (response rate 23%)
and 766 of them (45%) screened positive and were
contacted by telephone. Based on predefined exclu-
sion criteria 158 (21%) patients were excluded. Exclu-
sion criteria were suicidal ideation and behavior,
dementia or other severe cognitive disorders, psych-
otic disorder, bipolar disorder, dependence on alcohol
or drugs, severe unstable somatic condition, insuffi-
cient knowledge of the Dutch language, GP diagnosis
of anxiety or depression or psychological treatment in
the six months before the start of the study. Of the
remaining 608 patients, 164 (27%) patients did not provide
informed consent. Therefore, 444 patients screening posi-
tive for anxiety and depression were included in the
present study. GPs were blind to which patients had en-
tered the study. For further details on recruitment and se-
lection we refer to the study protocol [33].
Measures
Outcome measure
The outcome in the present study was GPs’ recognition
of anxiety or depression, as evidenced by information
that was available in the patients’ medical records, in the
time period from 6 months before to 6 months after the
EK-10 screening. Information that was deemed to be in-
dicative of recognition was the presence of terms de-
scribing: (i) psychological complaints: anxiety,
depression, worrying, sorrow or grief, stress, feeling
down, disordered sleeping and unexplained somatic
symptoms; (ii) International Classification of Primary
Care-1 (ICPC-1) diagnostic codes [41] for anxiety, de-
pression and related psychological problems i.e. acute
stress, feeling anger or irritation, behaving irritably or
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angrily, neurasthenia, or (iii) Four-Dimensional Symp-
tom Questionnaire (4DSQ) scores. The 4DSQ can be
used to help recognize anxiety and depressive disorders.
This self-report instrument can be used to distinguish
between stress-related syndromes (termed ‘stress’, ‘burn-
out’ and ‘nervous breakdown’) and psychiatric disorders
(i.e. anxiety and depressive disorders) [42]. Recognition
was operationalised this way because diagnostic coding
alone strongly underestimates the accuracy of the GP
[14, 43]. The medical records were retrospectively
searched by two researchers. They assessed 50 medical
records independently and weighted kappa statistics
were calculated. The kappa yielded an inter-rater agree-
ment of 96% (weighted kappa = 0.91; 95% CI: 0.79–1.00).
Patient and GP related factors
The independent variables investigated included patient
and GP characteristics that might be associated with the
recognition of anxiety and depression. The data were
collected at baseline.
Patient characteristics were age, married or living to-
gether, presence of a chronic medical condition, psycho-
logical symptoms, perceived need for psychological care
and functional status. Chronic medical condition was
measured with the Dutch Central Bureau of Statistics
(CBS) list, a questionnaire containing 28 conditions [44].
Psychological symptoms were measured with the
Four-Dimensional Symptom Questionnaire (4DSQ). The
4DSQ has four subscales relating to common psycho-
pathology: distress, depression, anxiety and somatisation;
high scores correspond to high symptom levels. Per-
ceived need for psychological care (henceforth “need for
care”) was measured with two questions after the 4DSQ:
“Do you receive any help for these complaints” and “Do
you need help to solve these complaints”, answered with
yes/no. Functional status was measured using the World
Health Organisation’s Disability Assessment Scale II
(WHODAS II) which covers functional impairments in
six domains over the past thirty days. The standardised
total score, based on 32 items corrected for missing
values was calculated [45, 46]. The domains are commu-
nication and understanding, getting around, self-care,
getting along with people, life activities and participation
in society. Scores range from 0 to 100; high scores indi-
cate functional impairment.
GP characteristics were attitudes to anxiety and de-
pression, measured with the Depression Attitude Ques-
tionnaire (DAQ) [47, 48] and with the REASON
questionnaire [49]. The DAQ measures GPs’ interest in
and attitudes toward depressive disorders; respondents
are asked to indicate the degree to which they agree or
disagree (a 7-point Likert scale in which the discrete an-
chor points were converted to a 0–100 scale, where 0
means strongly disagree and 100 strongly agree) with 20
statements based on their day-to-day clinical experience.
The DAQ consists of 4 components: treatment attitude
(high scores indicate a preference for antidepressant
drugs, low scores for psychotherapy); professional un-
ease (high scores indicate discomfort in dealing with de-
pressed patients, perception that treating depression is
unrewarding and that patients would be better off being
managed by a specialist); depression malleability (high
scores indicate pessimism about one’s ability to modify
the course of depression) and depression identification
(high scores indicate difficulty in differentiating depres-
sion from unhappiness, believes that it originates from
recent misfortunes, and that there is likely to be little
additional benefit beyond a GP’s own treatment. The
REASON measures GPs’ attitudes to their role in the
management of patients with depressive and anxiety dis-
orders (scores can range from 1 to 7), and comprises
two subscales: (i) professional comfort with and compe-
tence in care of mental health disorders (low scores indi-
cate comfort and competence) and (ii) GPs’ concerns
about problems with the health care system for manage-
ment of anxiety and depression (low scores indicate con-
cerns about difficulties).
Statistical methods
Multiple imputation was used, creating 5 complete data-
sets to deal with missing values. The imputation model
included recognition, condition (intervention or con-
trol), patient characteristics (gender, age, born in the
Netherlands, married or living together, in paid employ-
ment, level of education, 4DSQ score, WHODAS II
score, chronic medical condition, need for care, living
conditions), and GP characteristics (attitude towards
anxiety and depression). Missing values for recognition
(n = 24), born in the Netherlands (n = 8), married or liv-
ing together (n = 5), level of education (n = 4), living con-
ditions (n = 3), 4DSQ score (4DSQ Distress n = 11,
4DSQ Depression n = 11, 4DSQ Anxiety n = 12, 4DSQ
Somatization n = 30), WHODAS II score (n = 17), need
for care (n = 34) were imputed.
The prediction of recognition was examined using
multilevel logistic regression analyses. Logistic regression
was used because of the binary character of the outcome
variable (recognition yes/no). Multilevel analysis was
used to account for the clustered design (i.e., patients
were clustered within GPs and GPs were clustered
within practices), which threatens the mutual independ-
ence of the observations [50]. Not taking into account
the clustered nature of the data, results in
under-estimation of standard errors and over-estimation
of statistical significance. The analyses were performed
using the Generalized Linear Mixed Models method as
implemented in the Statistical Package for the Social Sci-
ences (SPSS) 22 program. All analyses were conducted
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in the 5 imputed datasets and results were pooled using
Rubin’s rules [51]. We considered 15 potential predictors
of recognition, ensuring not to exceed the limit of 10%
of the number of events (i.e. recognition, n = 160) in the
sample [52]. First, potential predictors (patients and GP
characteristics) were tested through trivariate analyses
using recognition as dependent (outcome) variable and
condition as effect modifier. The reason to take the trial
intervention (condition) into account as a possible effect
modifier was that the intervention might have affected
the effect of certain predictors on recognition. Predictors
and interaction terms with p-values < 0.20 were selected
for inclusion in a multivariate logistic regression model.
Then stepwise backward selection was used to remove
non-significant (p > 0.05) predictors and interaction
terms one-by one from the model, starting with predic-
tors and interaction terms with the highest p-value. To
assess the extent to which the predictors and interac-
tions retained in the final model actually explained the
variance in recognition, a receiver operating characteris-
tic (ROC) analysis was conducted using the
model-predicted probabilities as test variable and recog-
nition as the outcome variable. The area under the ROC
curve (AUC) ranges from 0.5 and 1.0 with larger values
indicating more variance explained [53].
Results
Characteristics of the study population
Baseline characteristics for patients and GPs are given in
Table 1. The mean age of the 444 patients was 54 years,
and 69% were female. The mean age of the 46 GPs was
49 years, and 54% were men.
The association of patient and GP characteristics with
recognition
GPs recognized anxiety or depression in 160 patients
(36%). Recognition rates were especially higher in pa-
tients who: were younger than 55 years, had a 4DSQ
Distress score of ≥11, had a perceived need for psycho-
logical care, and a WHODAS II score of ≥21 (see
Additional File 1). Table 2 shows the results of the tri-
variate and multivariate analyses. Ten predictors and/or
their interaction terms with condition had p-values <
0.20 in the trivariate analyses and were entered in a
multivariate model (in Table 2 indicated by a “‡” sign
after the p-value). After the backward selection proced-
ure only 4 predictors and one interaction term remained
in the final model. Patients with higher 4DSQ distress
scores (OR = 1.03; 95% CI 1.00–1.07) were significantly
more likely to be recognized. Note that the OR of 1.03 is
related to 1 point difference in the Distress score (range
0–32). To illustrate, if a person with 10 points on the
Distress scale has a probability of 30% of being recog-
nized, a person scoring 25 points has a probability of
40%. Also patients who had reported a need for care
(OR = 2.54, 95% CI 1.60–4.03) were significantly more
likely to be recognized. In addition, patients’ anxiety or
depression was less likely to be recognized when GPs
had less confidence in their abilities to identify depres-
sion (DAQ subscale depression identification; OR = 0.97;
95% CI 0.95–0.99). Married or living together was the
only predictor showing an interaction with condition,
suggesting that being married or living together was a
predictor of recognition only in the intervention condi-
tion but not in the control condition. Actually, recogni-
tion was lowered in patients who were married or living
together in the intervention condition (OR = 0.39; 95%
CI 0.16–0.95). The ROC analysis showed an AUC of
0.698 (95% CI 0.645–0.751) suggesting that the amount
of variance in recognition explained by the joint predic-
tors in the final model was “poor” to “fair” [53]. Patients’
Table 1 Baseline characteristics of primary care participants
(n = 444*) and general practitioners (n = 46). Values are numbers
(percentages) unless stated otherwise
Patient characteristics
Mean (SD) age (years) 54.3 (15.8)
Married or living together (n = 439) 294
(67.0%)
Number of chronic medical conditionsa(range: 0–28),
mean (SD)
3 (2.1)
4DSQb Distress score (range: 0–32), mean (SD) (n = 433) 12.2 (7.6)
4DSQ Depression score (range: 0–12), mean (SD) (n = 433) 1.7 (2.7)
4DSQ Anxiety score (range: 0–24), mean (SD) (n = 432) 3.0 (3.7)
4DSQ Somatisation score (range: 0–32), mean (SD) (n =
414)
8.4 (5.9)
Functional statusc(n = 427) 23.9 (15.7)
Need for care (n = 410) 201 (49%)
General Practitioner characteristics
DAQd mean score (SD)
Treatment attitudes (range 0–100) 44.3 (7.2)
Professional unease (range 0–100) 44.9 (7.8)
Depression malleability (range 0–100) 40.1 (11.0)
Depression identification (range 0–100) 46.6 (11.1)
REASONe mean score (SD)
Professional comfort with and competence in care of
mental health problems (range 1–7)
3.2 (0.4)
GPs’ concerns about problems with the health care
system for treatment of anxiety and depression (range
1–7)
4.4 (0.8)
*n = 444 unless stated otherwise
aChronic medical condition was measured with the Dutch Central Bureau of
Statistics (CBS) list
b4DSQ = Four-Dimensional Symptom Questionnaire
cFunctional status was measured with the WHODAS-II = World Health
Organisation’s Disability Assessment Scale II (excluding work)
dDAQ: Depression Attitude Questionnaire
eREASON questionnaire: GPs’ attitudes to their role in the management of
anxiety and depressive disorders
Sinnema et al. BMC Family Practice  (2018) 19:99 Page 4 of 10
age, the presence of a chronic medical condition, the 4DSQ
scores for somatisation, anxiety and depression, and pa-
tients’ functional status were not associated with the recog-
nition of anxiety and depression. In addition the DAQ
subscales treatment attitude, professional unease and
depression malleability were not associated with recogni-
tion. As well as the REASON subscales professional com-
fort with and competence in care of mental health disorders
and GPs’ concerns about problems with the health care sys-
tem for management of anxiety and depression.
Table 2 Results of the trivariate and multivariate multilevel logistic regression analyses predicting recognition of anxiety and
depression
Independent variables (predictors) Trivariate analysis Multivariate analysis
OR 95% CI P OR 95% CI P
Condition (intervention/control) 1.50 0.94–2.39 0.087 ‡ 3.08 1.47–6.46 0.003
Age 0.98 0.96–1.00 0.060 ‡
ConditionaAge 1.00 0.97–1.03 0.989
Married or living together (ref. not married or living together) 1.40 0.77–2.52 0.268 ‡ 1.25 0.67–2.35 0.478
ConditionaMarried or living together 0.33 0.14–0.79 0.013 ‡ 0.39 0.16–0.95 0.039
Number of chronic medical conditionsa 0.94 0.83–1.08 0.389
ConditionaNumber of chronic medical conditions 1.03 0.85–1.25 0.784
4DSQb
Distress 1.03 0.99–1.07 0.098 ‡ 1.03 1.00–1.07 0.024
ConditionaDistress 1.04 0.99–1.10 0.153 ‡
Depression 1.04 0.95–1.15 0.393
ConditionaDepression 1.03 0.89–1.16 0.666
Anxiety 1.02 0.94–1.10 0.615
ConditionaAnxiety 1.04 0.93–1.15 0.512
Somatization 1.01 0.96–1.06 0.736
ConditionaSomatization 1.04 0.97–1.11 0.301
Need for care (ref. no need for care) 2.77 1.56–4.91 0.001 ‡ 2.54 1.60–4.03 0.000
ConditionaNeed for care 1.18 0.49–2.85 0.719
DAQc
Treatment Attitudes 1.02 0.97–1.06 0.508
ConditionaTreatment Attitudes 0.96 0.88–1.04 0.294
Professional Unease 0.98 0.94–1.02 0.322 ‡
ConditionaProfessional Unease 1.05 0.99–1.11 0.137 ‡
Depression Malleability 0.98 0.95–1.00 0.084 ‡
ConditionaDepression Malleability 1.03 0.99–1.07 0.150 ‡
Depression identification 0.96 0.94–0.99 0.003 ‡ 0.97 0.95–0.99 0.018
ConditionaDepression identification 1.04 0.99–1.10 0.089 ‡
REASONd
Comfort and competence with mental health care 0.52 0.27–1.03 0.060 ‡
ConditionaComfort and competence with mental health care 2.52 0.90–7.07 0.079 ‡
Concerns about difficulties with the health care system 1.26 0.85–1.88 0.253 ‡
ConditionaConcerns about difficulties with the health care system 0.67 0.38–1.18 0.170 ‡
Functional statuse 1.00 0.98–1.02 0.662 ‡
ConditionaFunctional status 1.03 1.00–1.05 0.055 ‡
Reference category: No recognition; OR = odds ratio; 95% CI = 95% confidence interval; P = p-value, ‡ variables entered in the multivariate model
aInteraction term
b4DSQ Four-Dimensional Symptom Questionnaire
cDAQ Depression Attitude Questionnaire
dREASON questionnaire: GPs’ attitudes to their role in the management of anxiety and depressive disorders
eFunctional status was measured with the WHODAS-II World Health Organisation’s Disability Assessment Scale II
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Discussion
Main findings
The results of this study indicate that patients with a
perceived need for psychological care and those with
high distress were more likely to be recognized by their
GP as having anxiety or depression. This may not come
as a big surprise. After all, it is very likely that patients
who felt a need for care were more willing to disclose
their mental health problems and express their need for
care in the doctor’s office, thereby obviously increasing
the likelihood of subsequent recognition. Similarly, high
distress is experienced as “having a difficult time” and
this is probably close to having a need for support, ad-
vice or guidance. What is more surprising, is that high
depression and anxiety were not associated with recogni-
tion after accounting for distress. It seems that the sever-
ity of psychological suffering (i.e. distress) is associated
with recognition, rather than the severity of anxiety and
depression. No association was found between
somatization and recognition. The presentation of som-
atic complaints unexplained by physical illness (i.e.
somatization) may hinder recognition of anxiety and de-
pression, but this was not confirmed in our study. On
the GP part, we found that GPs with confidence in their
ability to identify depression were more inclined to
recognize patients having anxiety or depression. Besides,
GPs who had received the tailored intervention were
relatively less likely to recognize anxiety and depression
in patients who were married or living together. Possibly,
GPs in the intervention group were more focused on the
recognition of anxiety and depression particularly in
high-risk groups, including people having little or no so-
cial support.
In our study the amount of variance in recognition ex-
plained by the joint factors in the final model was “poor”
to “fair”. Recognition seems to be largely determined by
other factors, which we can only speculate about. On
the part of the GP, we can think of experience with men-
tal health problems, perceived professional responsibil-
ities, sensitivity to emotions, and workload. On the
patient part, we might think of past mental health prob-
lems, experience with mental health issues in relatives or
friends, openness to own emotions, and stigma. On the
part of the context of the doctor-patient encounter, we
can think of the duration and quality of the
doctor-patient relationship, the time available for a con-
sultation (time pressure), and giving priority to one com-
plaint after presentation of various complaints in one
consultation.
Comparison with existing literature
Previous studies have identified patient and GP charac-
teristics that are associated with the recognition or diag-
nosis of anxiety and depression. However, results are
difficult to compare because different definitions of rec-
ognition were used, as well as different instruments for
the assessment of anxiety and depression.
In our study high 4DSQ distress scores were associ-
ated with the recognition of anxiety and depression. Pre-
vious research showed that the 4DSQ distress scale
turned out to be effective in detecting any depressive or
anxiety disorder [54]. Remarkably, high 4DSQ scores on
the subscales anxiety and depression were not associated
with recognition. The finding is in line with the study of
Marcus et al. (2011) [27]. Patients in this study com-
pleted four symptom severity self-report questionnaires
(i.e. Penn State Worry Questionnaire, Beck Depression
Inventory II, Anxiety Sensitivity Index and Mini Social
Phobia Inventory) and no association was found with
the detection of anxiety and depression. In contrast,
other studies showed that patients with more anxiety or
depressive symptoms were more likely to be recognized
or diagnosed [7, 14, 24–26, 29, 55]. Although instru-
ments used in these studies were different from our
study (respectively the Beck Anxiety Inventory, the
Depression Screening questionnaire, General Health
Questionnaire, Center for Epidemiological Studies –
Depression Scale, the Composite International Diag-
nostic Interview and the Patient Health Questionnaire
9), research showed that correlations between the
4DSQ scales and other symptom questionnaires were
positive [42]. Furthermore, in keeping with the study
of Piek et al. (2012), we found no association between
the presence of chronic medical illness and recogni-
tion of anxiety and depression [7]. Coventry et al.
(2011) found that in the presence of chronic physical
health problems GPs and patients tend to normalise
distress and depression. As a consequence, depression
is less frequently recognized. In addition, Hermanns
et al. (2013) concluded in a review that diagnosis and
treatment of depression in people with chronic illness
(i.e. diabetes) can be improved [56]. An estimated
50% of patients remain undiagnosed. Other studies,
on the other hand, demonstrated a positive association be-
tween physical illnesses and recognition [25, 27]. Possibly,
in these studies patients with chronic somatic diseases vis-
ited their GP more frequently and, as a consequence, were
more likely to be recognized. Furthermore, in line with
other studies, no association was found between age and
recognition [7, 26, 27]. In contrast, a few studies found
that patients of higher age were more likely to be recog-
nized [14, 24]. An explanation for this finding might be
that anxiety disorders are most common in people aged
between 25 and 44 years [57]. In the study of
Wittchen et al. (2001) most patients were older [24].
Finally, the finding that patients’ need for care was a
significant predictor of recognition was confirmed in
previous research [27].
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With respect to the GP characteristics, GPs’ attitudes
towards anxiety and depression and their ability to de-
tect these disorders were rarely studied. One study ex-
amined the associations between attitudes, measured
with the DAQ, and clinical behaviour, including depres-
sion identification [30]. When comparing both study
populations, GPs score on the DAQ components 1, 2
and 4 are similar in our study. GPs score on component
3 ‘depression malleability’ differs significantly between
both studies (GPs score in our study was 40.1 and in the
study of Dowrick 24.5). In the study of Dowrick et al.
(2000) GP visitors completed the General Health Ques-
tionnaire 12 (GHQ-12) before the consultation and the
GP rated each patient on the severity of their psycho-
logical disturbance ranging from ‘no disorder’ to ‘severe
disorder’ after the consultation. Dorwick et al. (2000)
found no association between GPs’ confidence in their
identification of depression and the accuracy in identify-
ing it among their patients [30]. In contrast, our study
showed that GPs having confidence in the ability to
identify depression were more likely to recognize pa-
tients with anxiety or depression. Possibly, Dorwick et
al. (2000) found no association because they used a less
specific measurement instrument for the identification
of depression, the GHQ-12 which measures general dis-
tress [30]. In our study we determined recognition in pa-
tient medical records and with several indicators.
Strengths and limitations
A strength of this study was that we identified recogni-
tion using multiple indicators in the medical records.
Using diagnostic codes alone may underestimate the ac-
curacy of GPs’ recognition of anxiety and depression
[14, 43]. In addition, data on recognition was gathered
longitudinally, 6 months before and 6 months after pa-
tients completed the EK-10 and were included. Com-
pared to cross-sectional methods, record extraction over
an extended period may improve the accuracy of recog-
nition [12, 13]. For example, because patients may ex-
press their psychological complaints in repeated
consultations. However, there are inherent methodo-
logical limitations when using medical records: complex-
ities in the definition of recognition, recording,
assessment and in the exercise of clinical judgement in
negotiating diagnoses. Another limitation was that a
self-report questionnaire, the EK-10, was used as refer-
ence standard for including the participants in this
study. Although the EK-10 is an instrument for screen-
ing for anxiety and depressive disorders in general prac-
tice, a more reliable instrument as reference standard for
diagnosis would have been the Composite International
Diagnostic Interview (CIDI) [58]. On the other hand,
using the EK-10 can also be considered to constitute a
strength of the study, providing a wide definition of
anxiety and depression in keeping with the relatively
non-specific, heterogeneous nature of mental health
conditions in general practice.
Creating a regression model using a stepwise proced-
ure to select independent variable in the final model,
carries the risk of capitalizing on chance, i.e. the risk of
inclusion of variables that coincidentally show significant
associations with the outcome in a particular sample.
The role of marital status in the recognition of anxiety
and depression may have been a chance finding.
By design, by including only positively screened pa-
tients, our study did not provide any information on
false-positive recognitions.
Practical implications and further research
Recognition of anxiety and depression is important be-
cause of its association with appropriate treatment ac-
cording to guidelines [59]. Recognition could improve
when GPs have more insight in factors associated with
the recognition of anxiety and depression. Quality im-
provement activities may focus at increasing the confi-
dence of GPs in their ability to identify symptoms of
distress, anxiety and depression. Smolders et al. (2010)
showed that GPs with strong confidence in their abilities
to identify depression, treated their patients more often
in accordance with guidelines than GPs who had diffi-
culties with distinguishing depression from unhappiness
[60]. The use of an instrument, such as the 4DSQ may
be helpful to structure the dialogue with the patient, for
a better understanding of the complaints and for coming
to a shared understanding of the patient’s problem [39].
In the presence of chronic physical health problems,
GPs and patients have a tendency to normalise distress
[18] and may prioritise physical problems [19]. Using the
4DSQ may prevent normalisation of distress. The instru-
ment is helpful in informing the patient and GP about
the distress level. A high score (≥ 21) indicates a serious
problem, such as a clinically significant psychiatric dis-
order. Hermanns et al. (2013) concluded that “self-as-
sessment questionnaires can dramatically improve
depression detection rates. Complementing such screen-
ing with assessments of psychological distress can have
an additional and complementary impact on individual
self-care” [56]. When using an instrument for recogni-
tion, it is important that the instrument fits the holistic
focus of patient-centred consultation models favoured
by GPs [61]. Certainly, recognition alone is not effective,
it has to be part of care including accurate diagnosis,
follow-up, and access to evidence-based treatments
[62, 63]. Patients have to be informed about their
anxiety and depression, about evidence-based treat-
ment options (including watchful waiting) and pa-
tients have to express their preferences. In case of
major depressive disorders patients have to be
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convinced to initiate and continue treatment [63].
Furthermore, because patients with a perceived need
for psychological care were more likely to be recog-
nized, patients should be encouraged in disclosing
their problems. Further research is needed into which
strategies (individual- and societal level) are effective
to disclose mental health problems.
In our study the focus was on factors contributing to
the recognition of anxiety and depression in general
practice, a small part of quality improvement in primary
care. For sustainable improvements in primary mental
health care integration with community engagement
may contribute to a better recognition of anxiety and de-
pression by the GP [64].
Conclusion
Patients with a perceived need for psychological care
and those with high distress were more likely to be rec-
ognized by their GP as having anxiety or depression. In
addition, GPs with confidence in their ability to identify
depression were more likely to recognize patients with
anxiety or depression. Educational efforts should con-
centrate on increasing GPs’ confidence in the ability to
identify symptoms of distress, anxiety and depression, as
part of care according to guidelines. In addition, patients
should be encouraged to disclose their mental health
problems.
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